- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/15 - Sang; Sang artificiel cellules présentatrices d’antigène, p.ex. cellules dendritiques,
Détention brevets de la classe A61K 35/15
Brevets de cette classe: 1518
Historique des publications depuis 10 ans
|
67
|
113
|
107
|
179
|
165
|
167
|
208
|
230
|
147
|
61
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 18943 |
33 |
| The Trustees of the University of Pennsylvania | 4122 |
25 |
| Myeloid Therapeutics, Inc. | 52 |
25 |
| Children's Medical Center Corporation | 1780 |
15 |
| Snipr Technologies Limited | 50 |
15 |
| The General Hospital Corporation | 4517 |
14 |
| Yale University | 2204 |
14 |
| RegenLab USA LLC | 65 |
14 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
12 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
12 |
| Regents of the University of Minnesota | 2620 |
12 |
| Wisconsin Alumni Research Foundation | 3774 |
11 |
| Agency for Science, Technology and Research | 3512 |
11 |
| Baylor College of Medicine | 875 |
11 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
11 |
| Transimmune AG | 17 |
11 |
| President and Fellows of Harvard College | 5792 |
10 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 829 |
10 |
| Oncotherapy Science, Inc. | 302 |
10 |
| Cellis AG | 21 |
10 |
| Autres propriétaires | 1232 |